• landaulabnyu

Landau Lab collaborates with Carisma Therapeutics!

Updated: Nov 7, 2020

CARISMA Therapeutics Inc. now shares the license to use the vpx lentiviral vector created in our lab to facilitate the development of chimeric antigen receptor macrophages (CAR-M) targeting human epidermal growth factor receptor 2 (HER2), for the treatment of solid tumors.

Check out the official press release here.

16 views0 comments

Recent Posts

See All

Prof. Nathaniel R. Landau, PhD

 

Professor, Department of Microbiology

 

Member of the Microbial Pathogenesis Program

Full Bio.

Department of Microbiology

Alexandria Center for Life Science - West Tower

430 East 29th Street
Office Rm. 509, Lab Rm. 524
New York, NY 10016

Nathaniel.Landau@nyulangone.org


Direct Line: (212) 263-9197
Fax: (646) 501-4645

  • Twitter Social Icon

©2019 Landau Lab - Biomedical Research Lab at NYU - New York City